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PURPOSE. To assess the cortical structure and cerebral blood flow changes in the brain of
patients with primary open-angle glaucoma (POAG).
METHODS. High-resolution anatomical magnetic resonance imaging (MRI) and arterial spin
labeling (ASL)-MRI were performed in 23 POAG patients and 29 controls. Patients were
further divided into early-moderate and advanced groups based on mean deviation (MD)
cutoff of 12 dB. A baseline scan was obtained and repeated during visual stimulation to the
central preserved visual field in the more affected eye of POAG patients and a randomly
selected eye of controls. Gray matter volume (GMV) and cerebral blood flow (CBF)
throughout the whole brain were compared between patients and controls.
RESULTS. Compared to controls, a region with significant reduction of GMV was detected in
the anterior calcarine fissure of advanced POAG patients (P < 0.001, voxels ¼ 503, 1698
mm3). Patients with early-moderate POAG had resting CBF similar to that of controls.
However, a region with marked CBF decrease was detected in the anterior calcarine fissure of
advanced POAG patients (P < 0.001, voxels ¼ 1687, 13,496 mm3). The region with CBF
reduction in advanced POAG showed good colocalization with the region with GMV decrease
in this group. Following visual stimulation, patients with advanced POAG showed significantly
lower increase in CBF in the occipital lobes (P < 0.001, voxels ¼ 112, 896 mm3) as compared
to controls (P < 0.001, voxels ¼ 1880, 15,040 mm3) and early-moderate POAG (P < 0.001,
voxels ¼ 2233, 17,864 mm3).
CONCLUSIONS. Primary open-angle glaucoma patients demonstrate a disease severity–
dependent retinotopic pattern of cortical atrophy and CBF abnormalities in the visual cortex.
Cerebral blood flow may be a potential biomarker for the brain involvement in glaucoma.
Keywords: primary open-angle glaucoma (POAG), gray matter volume (GMV), cerebral blood
flow (CBF), magnetic resonance imaging (MRI), arterial spin labeling (ASL)
Glaucoma comprises a group of diseases characterized byprogressive retinal ganglion cell (RGC) loss, resultant optic
nerve head changes, and visual field loss and is a major cause of
irreversible blindness worldwide.1 Intraocular pressure (IOP)–
dependent and independent factors such as immune distur-
bance and vascular dysregulation have been implicated in the
onset and progression of this disease.2,3 More recently, several
independent studies have provided evidence for the involve-
ment of central visual targets in glaucoma. Marked neuronal
degeneration and glial activation have been confirmed in the
lateral geniculate nucleus (LGN) and visual cortex of nonhuman
primates as well as human patients with glaucoma.4–12 Atrophy
of the optic nerve, optic chiasm, optic tract, LGN, optic
radiation, and visual cortex associated with longstanding retinal
visual field defects in glaucoma has also been demonstrated in
vivo using magnetic resonance imaging (MRI).4,13–16 These
changes in the brain may directly perturb processing of visual
information or lead to further RGC loss and visual field defects
through neurotrophic factor deprivation.17 With advances in
modern neuroimaging techniques, early detection and in vivo
monitoring of the morphologic and functional changes in the
human brain are possible and provide tools and opportunities
for further investigation and understanding of the involvement
of the brain in glaucoma. In the central nervous system (CNS),
neurons and vascular cells form a functionally integrated
network that is collectively termed the neurovascular unit.
Alterations of the activity of the neurons may evoke dilation or
constriction of neighboring blood vessels to regulate local
blood flow perfusion.18 Accordingly, cerebral blood flow (CBF)
may be a potential indicator for the brain neuropathy in
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glaucoma. In a previous study we reported an insufficiency in
the hemodynamics in the posterior cerebral artery (PCA) of
patients with primary open-angle glaucoma (POAG).19 In the
present study, we further investigate the structural and CBF
changes in the brain of POAG patients using high-resolution
anatomical MRI and arterial spin labeling (ASL) perfusion MRI.
METHODS
Subjects
Primary open-angle glaucoma patients between 40 and 60
years of age were enrolled from Beijing Tongren Eye Center
and Department of Ophthalmology, Peking University Third
Hospital. The diagnosis of POAG was based on an IOP more
than 21 mm Hg, open anterior chamber angle, and glaucoma-
tous abnormalities of the optic nerve head with correlating
visual field defects. The relatively young age was chosen to
reduce the risk of a confounding effect of aging on the brain
structure and cerebrovascular system. Age- and sex-matched
controls were recruited by advertising the research project.
All participants underwent a comprehensive ophthalmolog-
ic examination, including visual acuity, refraction, Goldman
applanation tonometry, slit-lamp biomicroscopy, gonioscopy,
ophthalmoscopy, and nonmydriatic retinal photography. Visual
fields were assessed using the Humphrey 30-2 SITA standard
program (Carl Zeiss Meditec, Dublin, CA, USA) and retinal
nerve fiber layer (RNFL) thickness was measured using optical
coherence tomography (OCT; Carl Zeiss Meditec). All subjects
had a best-corrected visual acuity of 20/40 or better; a spherical
refraction within 65 diopters (D) and cylinder correction
within 63 D were permitted. All patients had established
visual field defects with at least the central 58 or more
preserved visual field in both eyes. Patients were further
divided into an early-moderate and an advanced glaucoma
group based on a mean deviation (MD) value in the visual field
of their more affected eye. Those with MD ‡ 12 dB were
classified as early-moderate glaucoma while those with MD <
12 dB were grouped as advanced glaucoma. Patients with
nonglaucomatous optic neuropathy, any retinopathy, opaque
media, and ocular diseases that could affect the visual field
were excluded, as were those with cardiovascular diseases,
CNS diseases, and any conditions or symptoms that precluded
MRI scanning.
The study adhered to the tenets of the Declaration of
Helsinki and was approved by the ethics committee of the
Peking University Third Hospital; informed consent was
obtained from all patients.
Magnetic Resonance Imaging
Magnetic resonance imaging was performed using a Trio 3.0
Tesla scanner (Siemens, Erlangen, Germany) with a 12-channel
receiver head coil. During testing, subjects lay supine in the
MRI scanner with two pieces of foam supporting the head to
minimize movement. Whole-brain high-resolution T1-weighted
anatomic scans were acquired with a four-echo magnetization-
prepared rapid gradient-echo imaging (MPRAGE) sequence (TR
¼2530 ms, TE¼1.64/3.5/5.36/7.22 ms, FOV¼2563256 mm2,
matrix ¼ 256 3 256).
Arterial spin labeling perfusion MRI, which uses magneti-
cally labeled arterial water as an endogenous tracer to obtain
quantified CBF maps, was performed with a pseudo-continu-
ous arterial spin labeling (pCASL) sequence (single-shot
gradient-echo echo-planar imaging, TR ¼ 4000 ms, TE ¼ 9.2
ms, FOV ¼ 220 3 220 mm2, matrix ¼ 64 3 64, and in-plane
resolution ¼ 3.4 3 3.4 mm2; 20 slices acquired in ascending
order with a slice thickness¼ 5 mm and a 1-mm gap between
slices; labeling duration¼ 1650 ms; post labeling delay¼ 1200
ms; and numbers of controls/labels ¼ 41 pairs). Scanning was
initially performed with both eyes of the subject covered with
an opaque occluder, and a total of 64 echo-planar imaging (EPI)
images were obtained in a 4.5-minute scan. Next, a 38
checkerboard reversing at 8 Hz was presented to central
preserved upper or lower hemifield of the eye with the more
severe visual field loss (Fig. 1). The eye and the choice of
central upper or lower hemifield to be tested in the control
group were selected at random. The temporal frequency of the
contrast-reversing checkerboard (8 Hz) was selected as it is
reported to elicit a maximum blood oxygen level–dependent
(BOLD) response from V1.20–24 Refractive error of the tested
eye was corrected with lenses fixed on the goggle; the fellow
eye was covered with an occluder attached to the goggle.
Computer-generated stimuli were back projected on a screen
that was located inside the MRI bore near the patient’s head.
The subjects were asked to fixate a cross at the center of the
screen, viewed at a total path length of 60 cm through a mirror
situated above their eyes. The session lasted for 4.5 minutes.
Image acquisition was started 4 to 6 seconds after the onset of
the visual stimuli presentation, and a total of 64 EPI images
were obtained.
Data Analysis
Voxel-Based Morphometry (VBM) Analysis. Automated
VBM analysis was conducted with VBM8 (http://dbm.neuro.
uni-jena.de/vbm/ [in the public domain]), which is an external
toolbox of the SPM8 software package (http://www.fil.ion.
ucl.ac.uk/spm/software/spm8/ [in the public domain]). Voxel-
based morphometry analysis assumes that each voxel of a T1-
weighted high-resolution MR image contains a mixture of gray
matter (GM), white matter (WM), and cerebrospinal fluid
(CSF). The image is segmented to yield the content or
probability of each tissue class at the voxel level. After
transforming each individual brain image into the same
stereotactic space, these voxel-based tissue probabilities can
be statistically compared between different populations to
determine local alterations of brain structure.25 In brief, for
each subject, the high-resolution structural image was first
segmented into different brain tissue including GM, WM, and
CSF and then normalized into standard Montreal Neurological
Institute (MNI) space (voxels resampled to isotropic 1.53 1.5
3 1.5-mm3) with the standard routine provided by VBM8. The
resulting images were visually checked to ensure that there
were no misclassifications; the modulated normalized GM
images that represented gray matter volume (GMV) images
were then smoothed using a Gaussian filter with a 6-mm full
width at half-maximum (FWHM) kernel. Finally, the group
difference between the patients and controls of GMV were
examined voxel-wise using the two-sample t-test model in SPM
with sex and age of subjects added to the model as covariates.
Areas of the brain that demonstrated significant differences
between groups were thresholded at P < 0.001 (cluster size ‡
40) and visualized in SPM with pseudo-color. These detected
regions were then looked up in the normalized human brain by
referring to the Automated Anatomical Labeling (AAL) system
(http://www.cyceron.fr/index.php/en/plateforme-en/freeware
[in the public domain]) system.
ASL Data Processing. Traditional image preprocessing
was carried out using SPM8 software for the ASL perfusion
data. Specifically, after abandoning the first two pairs of EPI
maps obtained in ASL scan to eliminate the effect of the
inhomogeneous magnetic field, perfusion images were re-
aligned and resliced to correct for head motion and mean
volume created. Subjects whose head motion exceeded 2.0
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mm or rotation exceeded 2.08 during scanning were excluded.
Structural images were coregistered with the mean volume of
functional images and subsequently smoothed using an 8-mm
FWHM isotropic Gaussian kernel in SPM8. Cerebral blood flow
images of the whole brain were then reconstructed from
preprocessed perfusion images using Grocer toolbox (http://
www.fil.ion.ucl.ac.uk/spm/ext/#Grocer [in the public do-
main]). The acquired CBF images were normalized to standard
MNI space and the voxels resampled to isotropic 2 3 2 3 2-
mm3. The mean CBF maps of patients (both early-moderate
and advanced POAG) as well as controls obtained both at rest
and during visual stimulation were modeled in a 23 2 factorial
design with SPM. In order to eliminate the baseline difference
of CBF across subjects, global mean scaling was done using the
proportional normalization method in the generalized linear
model (GLM). In line with the procedure done for the GMV
analysis, the brain areas showing significant difference in the
CBF between groups were also thresholded at P < 0.001
(cluster size ‡ 40). The visualization and name labeling of the
detected regions were done as in the VBM analysis. Global
mean CBFs of controls and patients were also extracted with
the global mean extraction tool provided in the Grocer
toolbox.
RESULTS
Twenty-three POAG patients, 14 males and 9 females with a
mean age of 47 6 7 years, completed the study. Nine patients
were defined as early-moderate glaucoma and 14 as advanced
glaucoma. The mean MD in the more and less affected eye was
18.6 6 9.6 and 10.4 6 7.2 dB, respectively. Twenty-nine
healthy volunteers (19 males and 10 females, mean age 48 6 7
years) were recruited as controls. Distribution of age (t ¼
0.730, P ¼ 0.469) and sex (v2 ¼ 0.119, P ¼ 0.732) was
comparable between glaucoma patients and controls.
Changes in Gray Matter Volume in the Primary
Visual Cortex of POAG Patients
Compared to controls, POAG patients showed significantly
reduced GMV in the anterior part of the calcarine fissure, the
region corresponding to the approximate anatomical projec-
tion zone of the peripheral visual field loss (Fig. 2A, P < 0.001
uncorrected, cluster size ‡ 40, voxels ¼ 102, 344 mm3). On
analyzing the early-moderate and advanced glaucoma groups, a
statistically significant GMV decrease was noticed only in the
anterior calcarine fissure of advanced POAG patients (Fig. 2C, P
< 0.001 uncorrected, cluster size ‡ 40, voxels ¼ 503, 1698
mm3). No GMV decrease was detected anywhere in the brain
in the early-moderate glaucoma group. A small region with
increased GMV was observed in the cuneus of early-moderate
POAG patients compared with controls (Fig. 2B, P < 0.001
uncorrected, cluster size ‡ 40, voxels ¼ 143, 483 mm3).
Resting Cerebral Blood Flow in the Primary Visual
Cortex of POAG Patients
At baseline, the mean CBF in POAG patients (42.18 6 1.49 mL/
100 g/min) was similar to that in controls (41.89 6 1.71 mL/
FIGURE 1. Visual field and optical coherence tomography measurements of a primary open-angle glaucoma (POAG) patient. (A) Humphrey Field
Analyzer (HFA) 30-2 program revealed bilateral visual field defect in this patient. (B) Optical coherence tomography examination illustrated retinal
nerve fiber layer (RNFL) thinning in the inferior temporal retina in both eyes. (C) According to the pattern of visual field loss in this patient,
hemifield black and white reversing checkerboard was presented to the preserved central inferior visual field of the right eye. OD, right eye; OS, left
eye.
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100 g/min) (independent 2-sample t-test, P¼ 0.898) (Fig. 3A).
An isolated regional decrease in CBF was detected in the
anterior part of the calcarine fissure of glaucoma patients (Fig.
3B, P < 0.001 uncorrected, cluster size ‡ 40, voxels ¼ 438,
3504 mm3). No CBF changes could be detected anywhere in
the brains of the early-moderate POAG group. A significant
decrease in CBF was demonstrated in the anterior calcarine
fissure in advanced glaucoma (Fig. 3C, P < 0.001 uncorrected,
cluster size ‡ 40, voxels ¼ 1687, 13,496 mm3). This brain
region with decreased CBF in the advanced glaucoma group
showed good colocalization with the region of decreased GMV
(Fig. 3D).
Reduced Visual Evoked Cerebral Blood Flow in the
Occipital Lobe of POAG Patients
When receiving monocular checkerboard stimulation, both
controls and POAG patients showed significantly increased
CBF in bilateral occipital poles as compared to their own
baselines (Figs. 4A, 4B). Voxels with increased CBF after visual
stimulation were significantly less in advanced POAG patients
(Fig. 4D, P < 0.001 uncorrected, cluster size ‡ 40, voxels ¼
112, 896 mm3) than in controls (Fig. 4A, P < 0.001
uncorrected, cluster size ‡ 40, voxels ¼ 1880, 15,040 mm3)
and early-moderate POAG patients (Fig. 4C, P < 0.001
uncorrected, cluster size ‡ 40, voxels ¼ 2233, 17,864 mm3).
DISCUSSION
We report a retinotopic reduction in the GMV and resting CBF
in the anterior calcarine fissure, the region corresponding to
the brain projection zone of peripheral visual field defect, in
patients with advanced POAG. This is also the first report of
compromised cerebral blood perfusion response in the
occipital poles to visual stimulation presented to the central
preserved ‘‘normal’’ visual field in patients with advanced
POAG. These findings provide further evidence for the brain
neurodegeneration in glaucoma and provide new evidence for
the involvement of the cerebrovascular system in the
pathophysiology of glaucoma. This highlights the potential
use of CBF as an indicator for the detection of brain changes in
glaucoma.
Atrophy of the visual cortex in glaucoma patients has been
demonstrated in several studies. Our results are consistent
with the MRI reports of Yu et al.26 and Bogorodzki et al.27 of
local cortical atrophy in the primary visual cortex of patients
with glaucoma. Boucard et al.13 also reported a similar GM
density decrease in the anterior part of the calcarine fissure in
glaucoma patients, as well as in the occipital poles of those
with age-related macular degeneration (AMD), who typically
suffer from central visual field loss. In patients with dementia
but without glaucoma, retinal neuronal damage as reflected by
thinning of the ganglion cell–inner plexiform layer (GC-IPL) is
associated with GM loss in the occipital and temporal lobes.28
The data consistently respect the topographical relationship
between brain involvement and retinal neurodegeneration.29
We detected regional GMV decrease in the anterior
calcarine fissure of advanced POAG but not in early-moderate
POAG. This is in agreement with a recent report of GM density
changes in advanced, but not early POAG.30 Yu et al.26
documented significant differences in calcarine cortical thick-
ness between mild and advanced glaucoma. Decreased cortical
thickness was detected in the V5/MTþ area in patients with
early glaucoma, while in advanced cases it was present in both
V5/MTþ and anterior subregions of V1.31 This finding is
consistent with the concept that the magnocellular pathway
may be affected earlier than the parvocellular pathway in
glaucoma.12 Although a primary neurodegenerative process in
the brain cannot be excluded, the retinotopic and disease
severity–related cortical changes in glaucoma suggest a type of
secondary anterograde transsynaptic degeneration, or cortical
plasticity, primed by the death of RGCs and absence of
stimulation from the areas of visual field defects in glaucoma.
Neurodegeneration in the visual cortex either may represent a
state of ‘‘dormancy’’ or may actively participate in the disease
progress through deprivation of brain-derived neurotrophic
factors.17 In recent years, a retinal prosthesis system (RPS) has
been under development as a potentially valuable aid for
restoring functional vision in those suffering from partial or
total blindness.32 It provides retinal stimulation and transmits
the signal via normal visual pathway to the visual cortex.
Patients with late-stage glaucoma, as well as other retinal
degenerative diseases, may benefit from the visual prosthesis;
but whether the brain atrophy in glaucoma could compromise
the effect of RPS needs further investigation. Findings in the
central visual targets in glaucoma may change its concept as an
FIGURE 2. Changes in the gray matter volume (GMV) in POAG patients. Colors indicate statistically significant difference in GMV, with yellow
indicating GMV decrease and blue indicating GMV increase in POAG patients compared with controls. (A) Gray matter volume reduction was
detected in the anterior part of calcarine fissure in patients with POAG. (B) Gray matter volume increase was detected in the cuneus in early-
moderate POAG patients compared with controls. (C) Region with significant GMV reduction was detected in the anterior calcarine fissure in
advanced POAG patients compared with controls.
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eye disease into a whole visual pathway neurodegenerative
condition and may affect our clinical practice in the future.
We found a small region with increased GMV in the cuneus
(Brodmann area, BA17) of early-moderate POAG patients. The
cuneus is a small lobe in the occipital lobe that receives visual
information from contralateral superior retina and projects
fibers to the extrastriate cortex. A GMV increase in the cuneus
may represent a compensation or replasticity of the visual
cortex following early visual field loss in glaucoma. Cortical
replasticity and cross-model plasticity have been widely
observed in the brain of glaucoma patients.30,33,34 Consistent
with our present results, Williams et al.33 previously reported
that patients with glaucoma may have volumetric gains in some
structures early in disease, but that brain volumes decrease
toward and in some cases below control volumes as the disease
progresses. Li et al.30 reported significantly decreased GMV in
the lingual gyrus, calcarine gyrus, postcentral gyrus, superior
frontal gyrus, inferior frontal gyrus, and rolandic operculum of
both sides, the right inferior occipital gyrus, left paracentral
lobule, right supramarginal gyrus, and right cuneus in POAG
patients. Increased GMV was detected in bilateral middle
temporal gyrus, inferior parietal gyrus, angular gyrus, and left
superior parietal gyrus, left precuneus, and the left middle
occipital gyrus in these patients.30 In another study, GM
density reduction was located bilaterally in the primary visual
cortex (BA17 and BA18) and paracentral lobule (BA5), right
precentral gyrus (BA6), right middle frontal gyrus (BA9), right
inferior temporal gyrus (BA20), right angular gyrus (BA39), left
praecuneus (BA7), left middle temporal gyrus (BA21), and
superior temporal gyrus (BA22) while increased GM density
was found in BA39. Altered integrity of WM tracts and brain
atrophy was detected in both visual cortex and other distant
nonvisual regions.34 Differences between studies could be due
to heterogeneity of patient groups or the different image
processing and averaging techniques employed. The data are,
however, consistent with the occurrence of cortical replastic-
ity in the brain of patients affected by glaucoma, a phenom-
enon that merits further investigation.
Our results support the notion that established neurode-
generation in the brain may be a late-onset event in glaucoma.8
Considering the role that brain changes may play in the process
of disease progression, biomarkers that can specifically and
sensitively reflect the brain changes in glaucoma may be useful
in disease evaluation and follow-up. In the CNS, changes in the
function, structure, or metabolism of neurons may lead to
disturbance of the local CBF through neurovascular cou-
pling.18,19,35 We hypothesized that glaucomatous neurodegen-
eration in the brain may be accompanied by cerebral vascular
deficiency. Cerebrovascular insufficiency in glaucoma has been
reported by a few previous clinical studies, and includes
abnormal CBF patterns, diffuse WM lesions, lacunar infarcts,
and hemodynamic disturbances in the middle cerebral artery
(MCA).36–43 We have previously reported insufficiency in the
hemodynamics and vasoreactivity of the PCA, the main
FIGURE 3. Comparison of the resting cerebral blood flow (CBF) perfusion between POAG patients and controls. (A) Comparable global mean CBF
between POAG patients and controls at baseline. (B) Region with CBF reduction (yellow) in the anterior part of calcarine fissure in POAG patients.
(C) Region with significant CBF reduction (yellow) in the anterior part of calcarine fissure in advanced POAG patients. (D) Overlay of the region
with decreased CBF (yellow) with that with decreased gray matter volume (GMV) (red) in advanced glaucoma patients.
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supplying vessel of the posterior visual pathways, in POAG.19 A
recent study reported reduction in the resting CBF in the
primary visual cortex and its correlation with the loss of visual
function in patients with POAG.44 These findings are evidence
of widespread involvement of the cerebrovascular system in
glaucoma. It has, however, remained unclear whether and how
cerebral vascular changes contribute to the brain neurodegen-
eration in glaucoma. The excellent colocalization of GMV
decrease and resting CBF reduction in the peripheral visual
field projection zones in the anterior calcarine fissure of
advanced POAG in the present study supports our hypothesis
of the role of neurovascular coupling in the brain changes that
occur in glaucoma.
In addition to glaucoma, disturbances of CBF or cerebro-
vascular reactivity have also been widely observed in patients
with Parkinson’s disease, Alzheimer’s disease, and multiple
sclerosis.45–47 These findings suggest a common involvement
of the neurovascular mechanism in neurodegenerative diseases
of the CNS. Dysregulated cerebrovascular reactivity may lead
to unstable oxygen supply to local neurons, and may actively
participate in the acceleration of neurodegeneration in the
brain of the patients. Investigations of the cerebrovascular
system may provide new insight into the pathogenesis of brain
changes in glaucoma.
The new finding in the present study is the decreased CBF
response to central visual stimulation in advanced POAG.
Despite the preserved central visual field in the stimulated
region and normal GMV in bilateral occipital poles, patients
with advanced POAG showed significantly compromised CBF
changes in the occipital poles in response to central visual
stimulation. This result is consistent with our previous
publication of decreased vasoreactivity in bilateral PCAs to a
reversing checkerboard stimulation presented to the central
preserved ‘‘normal’’ visual field in patients with POAG.19 In an
earlier functional MRI study, a 58 hemifield reversing checker-
board was presented monocularly to the central apparently
‘‘normal’’ visual field of patients with asymmetric POAG. A
significant decrease in blood oxygenation level-dependent
(BOLD) signal changes was observed in the occipital poles
when evoked by the glaucomatous eyes as compared to the
contralateral, less affected fellow eye.10 These and current
findings suggest that disruption in cerebral vascular responses
or cerebral blood perfusion may precede cortical structural
changes, as well as detectable visual field defects in POAG.
There may be a functional decrease in visual processing even in
the visual field we defined as the ‘‘normal’’ central area in
POAG. It has been reported that 25% to 35% of RGCs are lost
prior to detectable abnormality in automated visual field
testing.48 A flow-on effect of early perceptual loss may be
involved in the visual evoked cerebrovascular or CBF perfusion
insufficiency in glaucoma. A mechanism involving neurovas-
cular coupling cannot be excluded, as cortical neurons in the
occipital poles of advanced POAG patients may be functionally
inhibited or impaired. Decreased neuronal activity in this
FIGURE 4. Visual evoked cerebral blood flow (CBF) perfusion changes in controls and POAG patients. (A) Significant CBF increase in bilateral
occipital poles of controls (yellow). (B) Significant CBF increase in bilateral occipital poles of POAG patients (yellow). (C) Significant CBF increase in
bilateral occipital poles of early-moderate POAG patients (yellow). (D) Small region with weak CBF increase in the left occipital pole of advanced
POAG patients (yellow).
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region may disrupt the regulation of local arterioles and result
in impaired visual evoked cerebrovascular responses. Future
studies should examine the value of using CBF as a biomarker
for the diagnosis and prediction of brain alterations in
glaucoma.
There are several limitations to our study. First, to avoid the
effect of aging on the cerebral vascular system, only patients
between 40 to 60 years of age without a history of
cardiovascular disease were included. Our findings can be
extrapolated only to similar patients without systemic vascular
dysregulation, the presence of which may have a (currently
unknown) effect on the CBF in glaucoma. Second, although
SPM-based automated volumetric analysis is considered an
acceptable substitute for labor-intensive manual estimates,49
manual delineation-based volumetric assessment is traditionally
regarded as the gold standard for intracranial volumetric
analysis in brain degeneration.25,49 The use of the gold standard
method might make the results a little bit different. Third, we
compared the GMV and CBF between POAG patients and
controls across the whole brain, and only regions showing
significant differences between groups under a specific
threshold were referred to the Automated Anatomical Labeling
system of normalized human brain for localization. We
consider this a first step in exploring the mechanism of CNS
involvement related to glaucoma. Investigation of the structur-
al and cerebrovascular alterations in separated visual cortex
areas (e.g., V1/V2/V3 areas) would provide valuable informa-
tion.
In summary, this is the first report of a colocalized reduction
in the GMV and resting CBF in the brain projection zone of
glaucomatous visual field defects in advanced POAG. This
finding partly supports neurovascular coupling as a mechanism
of brain involvement in glaucoma. More importantly, the
occipital poles of advanced POAG patients that showed GMV
and resting CBF perfusion comparable with that of early-
moderate glaucoma patients and controls, demonstrated
significantly decreased CBF response to monocular visual
stimulation presented to the central apparently ‘‘unaffected’’
visual field. This raises the possibility of using CBF as an index
for the evaluation of central visual function or for detection of
brain changes in patients with glaucoma. Glaucoma provides a
model for the study of ‘‘neurovascular coupling mechanism’’ in
CNS neurodegenerative diseases. Whether patients with POAG
may benefit from neuroprotective therapies directed at the
entire visual pathway or at improving the regulation of cerebral
vasoreactivity in addition to conventional strategies for
lowering intraocular pressure is speculative.
Acknowledgments
Supported by National Nature Science Foundation of China Grants
81100661 and 91132302, Ministry of Science and Technology of
China Grant 2012CB825505, Postdoctoral Science Foundation of
China Grant 20100480170, and Key Lab Open Foundation of
Capital Medical University Grant 2010YKSJ04. The authors alone
are responsible for the content and writing of the paper.
Disclosure: S. Zhang, None; B. Wang, None; Y. Xie, None; S.
Zhu, None; R. Thomas, None; G. Qing, None; C. Zhang, None;
N. Wang, None
References
1. Quigley HA, Broman AT. The number of people with glaucoma
worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–
267.
2. Huang P, Qi Y, Xu YS, et al. Serum cytokine alteration is
associated with optic neuropathy in human primary open
angle glaucoma. J Glaucoma. 2010;19:324–330.
3. Resch H, Garhofer G, Fuchsjager-Mayrl G, Hommer A,
Schmetterer L. Endothelial dysfunction in glaucoma. Acta
Ophthalmol. 2009;87:4–12.
4. Chen WW, Wang N, Cai S, et al. Structural brain abnormalities
in patients with primary open-angle glaucoma: a study with 3T
MR imaging. Invest Ophthalmol Vis Sci. 2013;54:545–554.
5. Crawford ML, Harwerth RS, Smith EL III, Shen F, Carter-
Dawson L. Glaucoma in primates: cytochrome oxidase
reactivity in parvo- and magnocellular pathways. Invest
Ophthalmol Vis Sci. 2000;41:1791–1802.
6. Crawford ML, Harwerth RS, Smith EL III, Mills S, Ewing B.
Experimental glaucoma in primates: changes in cytochrome
oxidase blobs in V1 cortex. Invest Ophthalmol Vis Sci. 2001;
42:358–364.
7. Dai H, Morelli JN, Ai F, et al. Resting-state functional MRI:
functional connectivity analysis of the visual cortex in primary
open-angle glaucoma patients. Hum Brain Mapp. 2013;34:
2455–2463.
8. Gupta N, Ang LC, Noel de Tilly L, Bidaisee L, Yucel YH. Human
glaucoma and neural degeneration in intracranial optic nerve,
lateral geniculate nucleus, and visual cortex. Br J Ophthalmol.
2006;90:674–678.
9. Weber AJ, Chen H, Hubbard WC, Kaufman PL. Experimental
glaucoma and cell size, density, and number in the primate
lateral geniculate nucleus. Invest Ophthalmol Vis Sci. 2000;41:
1370–1379.
10. Qing G, Zhang S, Wang B, Wang N. Functional MRI signal
changes in primary visual cortex corresponding to the central
normal visual field of patients with primary open-angle
glaucoma. Invest Ophthalmol Vis Sci. 2010;51:4627–4634.
11. Zhang S, Wang H, Lu Q, et al. Detection of early neuron
degeneration and accompanying glial responses in the visual
pathway in a rat model of acute intraocular hypertension.
Brain Res. 2009;1303:131–143.
12. Yucel YH, Zhang Q, Weinreb RN, Kaufman PL, Gupta N. Effects
of retinal ganglion cell loss on magno-, parvo-, koniocellular
pathways in the lateral geniculate nucleus and visual cortex in
glaucoma. Prog Retin Eye Res. 2003;22:465–481.
13. Boucard CC, Hernowo AT, Maguire RP, et al. Changes in
cortical grey matter density associated with long-standing
retinal visual field defects. Brain. 2009;132:1898–1906.
14. Dai H, Mu KT, Qi JP, et al. Assessment of lateral geniculate
nucleus atrophy with 3T MR imaging and correlation with
clinical stage of glaucoma. AJNR Am J Neuroradiol. 2011;32:
1347–1353.
15. Ramli NM, Sidek S, Rahman FA, et al. Novel use of 3T MRI in
assessment of optic nerve volume in glaucoma. Graefes Arch
Clin Exp Ophthalmol. 2014;252:995–1000.
16. Hernowo AT, Boucard CC, Jansonius NM, Hooymans JM,
Cornelissen FW. Automated morphometry of the visual
pathway in primary open-angle glaucoma. Invest Ophthalmol
Vis Sci. 2011;52:2758–2766.
17. Johnson TV, Bull ND, Martin KR. Neurotrophic factor delivery
as a protective treatment for glaucoma. Exp Eye Res. 2011;93:
196–203.
18. Zonta M, Angulo MC, Gobbo S, et al. Neuron-to-astrocyte
signaling is central to the dynamic control of brain microcir-
culation. Nat Neurosci. 2003;6:43–50.
19. Zhang S, Xie Y, Yang J, et al. Reduced cerebrovascular
reactivity in posterior cerebral arteries in patients with
primary open-angle glaucoma. Ophthalmology. 2013;120:
2501–2507.
20. De Yoe EA, Bandettini P, Neitz J, Miller D, Winans P. Functional
magnetic resonance imaging (FMRI) of the human brain. J
Neurosci Methods. 1994;54:171–187.
21. Engel SA, Glover GH, Wandell BA. Retinotopic organization in
human visual cortex and the spatial precision of functional
MRI. Cereb Cortex. 1997;7:181–192.
Changes in GMV and CBF in POAG Patients IOVS j September 2015 j Vol. 56 j No. 10 j 6177
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/934392/ on 02/09/2017
22. Engel SA, Rumelhart DE, Wandell BA, et al. fMRI of human
visual cortex. Nature. 1994;369:525.
23. Sereno MI, Dale AM, Reppas JB, et al. Borders of multiple
visual areas in humans revealed by functional magnetic
resonance imaging. Science. 1995;268:889–893.
24. Tootell RB, Hadjikhani NK, Vanduffel W, et al. Functional
analysis of primary visual cortex (V1) in humans. Proc Natl
Acad Sci U S A. 1998;95:811–817.
25. Callaert DV, Ribbens A, Maes F, Swinnen SP, Wenderoth N.
Assessing age-related gray matter decline with voxel-based
morphometry depends significantly on segmentation and
normalization procedures. Front Aging Neurosci. 2014;6:124.
26. Yu L, Xie B, Yin X, et al. Reduced cortical thickness in primary
open-angle glaucoma and its relationship to the retinal nerve
fiber layer thickness. PLoS One. 2013;8:e73208.
27. Bogorodzki P, Piatkowska-Janko E, Szaflik J, Szaflik JP, Gacek M,
Grieb P. Mapping cortical thickness of the patients with
unilateral end-stage open angle glaucoma on planar cerebral
cortex maps. PLoS One. 2014;9:e93682.
28. Ong YT, Hilal S, Cheung CY, et al. Retinal neurodegeneration
on optical coherence tomography and cerebral atrophy.
Neurosci Lett. 2015;584:12–16.
29. Kaushik M, Graham SL, Wang C, Klistorner A. A topographical
relationship between visual field defects and optic radiation
changes in glaucoma. Invest Ophthalmol Vis Sci. 2014;55:
5770–5775.
30. Li C, Cai P, Shi L, et al. Voxel-based morphometry of the visual-
related cortex in primary open angle glaucoma. Curr Eye Res.
2012;37:794–802.
31. Yu L, Yin X, Dai C, et al. Morphologic changes in the anterior
and posterior subregions of V1 and V2 and the V5/MTþ in
patients with primary open-angle glaucoma. Brain Res. 2014;
1588:135–143.
32. da Cruz L, Coler BF, Dorn J, et al. The Argus II epiretinal
prosthesis system allows letter and word reading and long-
term function in patients with profound vision loss. Br J
Ophthalmol. 2013;97:632–636.
33. Williams AL, Lackey J, Wizov SS, et al. Evidence for widespread
structural brain changes in glaucoma: a preliminary voxel-
based MRI study. Invest Ophthalmol Vis Sci. 2013;54:5880–
5887.
34. Frezzotti P, Giorgio A, Motolese I, et al. Structural and
functional brain changes beyond visual system in patients
with advanced glaucoma. PLoS One. 2014;9:e105931.
35. Metea MR, Newman EA. Glial cells dilate and constrict blood
vessels: a mechanism of neurovascular coupling. J Neurosci.
2006;26:2862–2870.
36. Harris A, Zarfati D, Zalish M, et al. Reduced cerebrovascular
blood flow velocities and vasoreactivity in open-angle
glaucoma. Am J Ophthalmol. 2003;135:144–147.
37. Harris A, Siesky B, Zarfati D, et al. Relationship of cerebral
blood flow and central visual function in primary open-angle
glaucoma. J Glaucoma. 2007;16:159–163.
38. Akarsu C, Bilgili YK, Unal B, Taner P, Ergin A, Kara SA. Cerebral
hemodynamics in ocular hypertension. Graefes Arch Clin Exp
Ophthalmol. 2005;243:317–320.
39. Ong K, Farinelli A, Billson F, Houang M, Stern M. Comparative
study of brain magnetic resonance imaging findings in patients
with low-tension glaucoma and control subjects. Ophthalmol-
ogy. 1995;102:1632–1638.
40. Kitsos G, Zikou AK, Bagli E, Kosta P, Argyropoulou MI.
Conventional MRI and magnetisation transfer imaging of the
brain and optic pathway in primary open-angle glaucoma. Br J
Radiol. 2009;82:896–900.
41. Sugiyama T, Utsunomiya K, Ota H, Ogura Y, Narabayashi I,
Ikeda T. Comparative study of cerebral blood flow in patients
with normal-tension glaucoma and control subjects. Am J
Ophthalmol. 2006;141:394–396.
42. Stroman GA, Stewart WC, Golnik KC, Cure JK, Olinger RE.
Magnetic resonance imaging in patients with low-tension
glaucoma. Arch Ophthalmol. 1995;113:168–172.
43. Suzuki J, Tomidokoro A, Araie M, et al. Visual field damage in
normal-tension glaucoma patients with or without ischemic
changes in cerebral magnetic resonance imaging. Jpn J
Ophthalmol. 2004;48:340–344.
44. Duncan RO, Sample PA, Bowd C, Weinreb RN, Zangwill LM.
Arterial spin labeling fMRI measurements of decreased blood
flow in primary visual cortex correlates with decreased visual
function in human glaucoma. Vision Res. 2012;60:51–60.
45. Marshall O, Lu H, Brisset JC, et al. Impaired cerebrovascular
reactivity in multiple sclerosis. JAMA Neurol. 2014;71:1275–
1281.
46. Benedictus MR, Binnewijzend MA, Kuijer JP, et al. Brain
volume and white matter hyperintensities as determinants of
cerebral blood flow in Alzheimer’s disease. Neurobiol Aging.
2014;35:2665–2670.
47. Al-Bachari S, Parkes LM, Vidyasagar R, et al. Arterial spin
labelling reveals prolonged arterial arrival time in idiopathic
Parkinson’s disease. Neuroimage Clin. 2014;6:1–8.
48. Kerrigan-Baumrind LA, Quigley HA, Pease ME, Kerrigan DF,
Mitchell RS. Number of ganglion cells in glaucoma eyes
compared with threshold visual field tests in the same
persons. Invest Ophthalmol Vis Sci. 2000;41:741–748.
49. Malone IB, Leung KK, Clegg S, et al. Accurate automatic
estimation of total intracranial volume: a nuisance variable
with less nuisance. Neuroimage. 2015;104:366–372.
Changes in GMV and CBF in POAG Patients IOVS j September 2015 j Vol. 56 j No. 10 j 6178
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/934392/ on 02/09/2017
